Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cibus, Inc.
Report date March 01, 2023 · Filed June 02, 2023
Section 16 reporting ended · disclosed 2023-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,174 |
Reported balance
After 2023-05-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-31 · Grant · Acquired 15,533 · Balance 33,174 F1: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect teh one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2031-07-27 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-01 · Disposition to issuer · Disposed 200,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2031-07-27 | Direct | 200,000 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Grant · Acquired 200,000 · Balance 200,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2033-03-24 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-03-01 · Disposition to issuer · Disposed 490,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2033-03-24 | Direct | 490,000 |
Reported balance
After 2023-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-01 · Grant · Acquired 490,000 · Balance 490,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect teh one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023.
F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2023 Filed Jun 2, 2023 20:02 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 15,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,174 F1 · shares: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect teh one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect teh one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. F1 · balance_after: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect teh one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 16:08 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 16,025 | $0.34 | $5,448.50 |
DisclosureSEC source: 0001615594-23-000021 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 882,011 F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3326 to $0.355, inclusive. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 16:15 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 20,261 | $0.43 | $8,714.26 |
DisclosureSEC source: 0001615594-23-000016 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 898,036 F1 · shares: Shares were sold to cover withholding tax obligations of reporting person in connection with the vesting of Performance Stock Units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:20 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 68,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000008 · primary_doc.xml · nonDerivative · entry 2 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918,297 F2 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:20 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 473,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000008 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849,964 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 490,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 5 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2033-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 490,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 4 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 490,000 shares Expires 2033-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 200,000 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 3 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-07-27 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 200,000 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 2 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2031-07-27 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 16:44 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 47,877 | $0.15 | $7,061.86 |
DisclosureSEC source: 0001615594-23-000005 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,064 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| July 27, 2022 Filed Jul 28, 2022 17:18 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 4,059 | $0.22 | $892.98 |
DisclosureSEC source: 0001615594-22-000045 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,941 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:42 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 490,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001615594-22-000018 · primary_doc.xml · derivative · entry 3 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2032-03-24 F3 · derivative.exercise_date: Option vests as to 25% on each of the first four anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:42 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 163,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000018 · primary_doc.xml · nonDerivative · entry 2 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,000 F2 · shares: The Restricted Stock Units reported on this Form 4 vest in full on January 1, 2023. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:42 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 205,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000018 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,000 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 16:53 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 10,000 | $3.98 | $39,776.00 |
DisclosureSEC source: 0001615594-21-000096 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · price: The price reported in Column 4 is a weighted average. The shares were purchased in multiple transactions at prices ranging from $3.9250 to $4.05, inclusive. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 17:18 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantPerformance Stock Units · Derivative | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000078 · primary_doc.xml · derivative · entry 3 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2024-07-27 F3 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Calyxt common stock. The PSUs vest upon Calyxt's common stock achieving specified prices per share for all of the trading days in any 30 consecutive calendar day period within a three year performance period. F3 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Calyxt common stock. The PSUs vest upon Calyxt's common stock achieving specified prices per share for all of the trading days in any 30 consecutive calendar day period within a three year performance period. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 17:18 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 200,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001615594-21-000078 · primary_doc.xml · derivative · entry 2 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-07-27 F2 · derivative.exercise_date: The Option vests as to one-third (1/3) on each of the first three anniversaries of the date of the grant. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 17:18 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 50,000 | $3.65 | $182,500.00 |
DisclosureSEC source: 0001615594-21-000078 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · shares: The Restricted Stock Units vest as to one-third (1/3) on each of the first three anniversaries of the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.